Bacterial conjunctivitis is inflammation of the outermost layer of the eye and inner area of the eyelid. Bacterial conjunctivitis symptoms include swelling, watery eyes, and redness. Bacteria responsible for conjunctivitis include staphylococci, haemophilus, Chlamydia trachomatis, and streptococci. Children and geriatric population are highly prone to bacterial conjunctivitis, however, it affects people of all age groups. The increasing cases of bacterial conjunctivitis demand efficient medication, which supports the growth of bacterial conjunctivitis drugs market. Bacterial conjunctivitis spreads because of poor hygiene, immune compromise, ocular diseases such as dry eye, blepharitis, and contaminated cosmetics. It can be prevented by maintaining proper hygiene and also hand wash reduces the chances of bacterial conjunctivitis.
Bacterial Conjunctivitis Drug Market Taxonomy
By Disease Type;
By Treatment Type;
By Route of Administration;
By End User;
Increasing incidences of bacterial conjunctivitis and availability of generic drugs to fuel the market growth
The spread of ophthalmic bacterial infection increased the demand for antibacterial drugs for its treatment. According to National Center for Biotechnology Information (NCBI) 2013 report, in the U.S., there were around 6 million people affected by conjunctivitis. Bacterial conjunctivitis takes around a week to get completely cured and fluoroquinolones are the most preferred drug for the treatment of bacterial conjunctivitis. There are certain drugs in the market that are patented and their patents about to expire, this, in turn, is expected to increase the market for generic drugs, which are of less price as well. Moxeza, vigamox, besivance, and zymaxid are some of the most successful patented drugs about to expire. After patent expiry, these drugs lose their exclusivity, which leads to increase in use of generic drugs. The development of multi-drug resistant variants is expected to fuel the growth of bacterial conjunctivitis drug market. The unnecessary use of antibiotics causes the disease causing bacteria to chemically evolve themselves and become resistant to drugs. This, in turn, may lead to the prescription of strong medication, which includes corticosteroids and high dose of antibiotics.
Rising occurrence of bacterial conjunctivitis demands safe and efficient drugs, which leads to the development of new drugs, such as vancomycin ophthalmic ointment, that are in the clinical trial pipeline and few are pending for approval. Some of the major challenges faced by bacterial conjunctivitis drug market are patent expiry and awareness about the disease that it cures itself in a week. However, the shift in preference toward herbal treatment from pharmacological treatment is expected to create new opportunities in the bacterial conjunctivitis drug market. Moreover, herbal formulation based drugs are widely accepted, which in turn leads to the development and investment in herbal products for the treatment of bacterial conjunctivitis. The aforementioned scenario is expected to support the growth of bacterial conjunctivitis drugs market over the forecast period.
Developed regions support the growth of bacterial conjunctivitis drug market
On the basis of geography, bacterial conjunctivitis drug market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the bacterial conjunctivitis drugs market due to the presence of advanced healthcare facilities and reimbursement policies. Europe is the second largest region followed by Asia Pacific. Asia Pacific is expected to witness moderate growth over the forecast period owing to the high awareness about the disease among public and high per capita income.
Key Players in the Bacterial Conjunctivitis Drug Market
Some of the key players contributing to the bacterial conjunctivitis drug market growth are, Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., and Allergan Plc. For increasing market share, the companies adopt various strategies such as mergers and acquisitions. For instance, in 2015, Shire acquired Foresight Biotherapeutics to increase its ophthalmic product pipeline.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.[email protected]
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.